Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT07213973 · RECRUITING
Trial details
- NCT number
- NCT07213973
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2028-03-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.